6Noise-induced loss & ototoxicity

FTwo causes, one lesson

Noise and ototoxic drugs are grouped together for a reason: both attack the hair cells of the cochlea — noise by mechanical and metabolic overstimulation, drugs by chemical poisoning — and because mammalian hair cells do not regenerate, the damage is permanent and sensorineural. Unlike the conductive loss of chronic ear disease, there is no surgery to reverse it. The only effective intervention is to stop it happening, which is precisely what makes these causes a public-health story: the loss is irreversible, but the exposure is avoidable.

FTNoise and the dose that damages

Noise injury depends on a dose — how loud, for how long. The widely used NIOSH standard sets a recommended limit of 85 dBA for 8 hours, with a 3-dB exchange rate: because every 3 dB doubles the sound energy, every 3 dB louder halves the safe exposure time. The consequence is dramatic at the top of the scale — safe exposure falls from hours to minutes to seconds. Explore the dose below.

FNoise in the Indian environment

India presents the full range of hazardous noise: occupational exposure in textile mills, metalworking, construction and mining, often without hearing protection or enforced limits; environmental noise from dense traffic and ubiquitous horns in its cities; and recreational and cultural noise — amplified music, and the firecrackers of festival season whose peak levels can damage hearing within a single burst. Much of this exposure is unmonitored and unprotected, making noise a large and growing avoidable contributor to the sensorineural burden.

FTOtotoxic drugs

Several important drug classes poison the inner ear. The aminoglycoside antibiotics (streptomycin, gentamicin, amikacin, kanamycin) are classically cochleotoxic and vestibulotoxic, damaging hair cells in a dose-related way that can progress even after the drug is stopped. Platinum chemotherapy (cisplatin, carboplatin) causes high-frequency sensorineural loss, a particular concern in children treated for cancer. Loop diuretics and some other agents add to the list. In a setting where these drugs are sometimes used with limited audiometric monitoring, the avoidable toll is significant.

CThe tuberculosis connection

India carries one of the world's largest tuberculosis burdens, and the treatment of drug-resistant TB has long relied on injectable aminoglycosides and related agents (streptomycin, kanamycin, amikacin, capreomycin). Hearing loss is among the most common and disabling side-effects of these regimens — a cruel trade in which curing one disease causes another, permanent one. The shift toward newer, all-oral regimens for drug-resistant TB is, in part, a hearing-preservation story, and audiometric monitoring during such treatment is essential.

CA genetic susceptibility

Ototoxicity is not purely a matter of dose. A mutation in the mitochondrial 12S ribosomal RNA gene — m.1555A>G — confers heightened, sometimes catastrophic, susceptibility to aminoglycoside damage: a carrier can be rendered profoundly deaf by a single, ordinary dose. Because mitochondria are maternally inherited, the trait runs down the maternal line, and a family history of deafness after antibiotics is a vital warning. Where genetic testing is feasible, identifying carriers before prescribing an aminoglycoside can prevent an entirely needless deafness.[1993]

CRelevance to implantation

Noise and ototoxicity matter to the implant clinician in two ways. Most are preventable losses that should never reach the clinic, and the public-health task is exposure control and drug stewardship. But when the damage is severe and bilateral — a child deafened by aminoglycosides, or profound loss after ototoxic chemotherapy — the cochlea is destroyed but the auditory nerve usually intact, making such patients good candidates for cochlear implantation. The tragedy is that the same prudence that would have prevented the loss is what was missing.

From environmental and chemical causes we turn to one written into the genome — and to the marriage patterns that bring it to the surface: consanguinity and the genetics of deafness (Module 7).